生物活性
GSK461364 是polo样激酶1 (Plk1)的ATP竞争性抑制剂。
靶点信息
| PLK1 (Cell-free assay) | | | | |
| 2.2 nM(Ki) | | | | |
化学数据
| 目录号 | A10442 |
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 543.6 |
| Formula | C27H28F3N5O2S |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated.
In lyophilized form, the chemical is stable for36 months.
In solution, store at -20ºC and use within3 monthsto prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |
| CAS No. | 929095-18-1 |
| Synonyms | GSK 461364, GSK-461364 |
| SMILES | C[C@H](C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N |
溶解度
| In vitro (25°C) | DMSO | 9 mg/mL (16.55 mM) |
| Water | Insoluble |
| Ethanol | 27 mg/mL (49.66 mM) |
| In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 28 mg/mL |
*<1 mg/ml means slightly soluble or insoluble.
*Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
储备液配制
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
| 0.1 mM | 18.4 mL | 91.98 mL | 183.96 mL |
| 0.5 mM | 3.68 mL | 18.4 mL | 36.79 mL |
| 1 mM | 1.84 mL | 9.2 mL | 18.4 mL |
| 5 mM | 0.37 mL | 1.84 mL | 3.68 mL |
*The above data is based on the productmolecular weight 543.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
